|
| 36087794 | Metabolomic Profiles Differentiate Scleroderma-PAH From Idiopathic PAH and Correspond With Worsened Functional Capacity. | Chest | 2023 |
| 37478403 | Innovations in RNA therapy for hemophilia. | Blood | 2023 |
| 36974749 | Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4-Human Leukocyte Antigen-DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension. | J Am Heart Assoc | 2023 |
| 36685041 | A p53-TLR3 axis ameliorates pulmonary hypertension by inducing BMPR2 via IRF3. | iScience | 2023 |
| 36775986 | Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases. | J Extracell Vesicles | 2023 |
| 36628260 | Second International Pulmonary Hypertension/Heart Failure Symposium-Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary Vascular Disease Network. | Pulm Circ | 2023 |
| 36201758 | miR-roring Changes in Blood: miR-210 Reflects Hypoxic Disease Dynamics in Obstructive Sleep Apnea. | Am J Respir Crit Care Med | 2023 |
| 34528097 | Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension. | Cardiovasc Res | 2022 |
| 35732465 | Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension. | Life Sci Alliance | 2022 |
| 35795496 | Improved hospitalization rates in a specialty center for heart failure with preserved ejection fraction and pulmonary hypertension. | Pulm Circ | 2022 |
| 35575096 | Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension. | J Clin Invest | 2022 |
| 35465051 | miRNA/mRNA co-profiling identifies the miR-200 family as a central regulator of SMC quiescence. | iScience | 2022 |
| 35427414 | Defenestrated endothelium delays liver-directed gene transfer in hemophilia A mice. | Blood Adv | 2022 |
| 35634304 | VEGF Receptor 1 Promotes Hypoxia-Induced Hematopoietic Progenitor Proliferation and Differentiation. | Front Immunol | 2022 |
| 37117763 | Post-GWAS functional analysis identifies CUX1 as a regulator of p16<sup>INK4a</sup> and cellular senescence. | Nat Aging | 2022 |
| 36875282 | Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice. | Rev Cardiovasc Med | 2022 |
| 36671453 | Metabolic Maturation Exaggerates Abnormal Calcium Handling in a <i>Lamp2</i> Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease. | Biomolecules | 2022 |
| 36370005 | Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension. | J Am Heart Assoc | 2022 |
| 36176897 | Association between income and likelihood of right heart catheterization in individuals with pulmonary hypertension: A US claims database analysis. | Pulm Circ | 2022 |
| 36273529 | In silico identification and synthesis of a multi-drug loaded MOF for treating tuberculosis. | J Control Release | 2022 |
| 36034404 | Pulmonary Vascular Research Institute GoDeep: A meta-registry merging deep phenotyping datafrom international PH reference centers. | Pulm Circ | 2022 |
| 36195915 | Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study. | J Transl Med | 2022 |
| 35298304 | Endothelial Senescence: A New Age in Pulmonary Hypertension. | Circ Res | 2022 |
| 33420357 | Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension. | Cell Mol Immunol | 2021 |
| 33599144 | Increased Mortality in Patients With Preoperative and Persistent Postoperative Pulmonary Hypertension Undergoing Mitral Valve Surgery for Mitral Regurgitation: A Cohort Study. | J Am Heart Assoc | 2021 |
| 33905372 | Frataxin deficiency promotes endothelial senescence in pulmonary hypertension. | J Clin Invest | 2021 |
| 33788187 | Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension. | Adv Exp Med Biol | 2021 |
| 33565360 | Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells. | Am J Physiol Lung Cell Mol Physiol | 2021 |
| 33888254 | NHLBI-CMREF Workshop Report on Pulmonary Vascular Disease Classification: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2021 |
| 34583280 | Modeling of dilated cardiomyopathy by establishment of isogenic human iPSC lines carrying phospholamban C25T (R9C) mutation (UPITTi002-A-1) using CRISPR/Cas9 editing. | Stem Cell Res | 2021 |
| 34157861 | Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction. | Circulation | 2021 |
| 34102109 | Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis. | Cell Metab | 2021 |
| 34056915 | Simultaneous Pharmacologic Inhibition of Yes-Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic-co-Glycolic) Acid-Encapsulated Microparticles Improves Pulmonary Hypertension. | J Am Heart Assoc | 2021 |
| 33223140 | Ranolazine Improves Right Ventricular Function in Patients With Precapillary Pulmonary Hypertension: Results From a Double-Blind, Randomized, Placebo-Controlled Trial. | J Card Fail | 2021 |
| 31577451 | Activation of the Metabolic Master Regulator PPARγ: A Potential PIOneering Therapy for Pulmonary Arterial Hypertension. | Am J Respir Cell Mol Biol | 2020 |
| 33268556 | Correction: p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis. | Cancer Res | 2020 |
| 33294740 | SCUBE1 Controls BMPR2-Relevant Pulmonary Endothelial Function: Implications for Diagnostic Marker Development in Pulmonary Arterial Hypertension. | JACC Basic Transl Sci | 2020 |
| 32726562 | A New "TYK" Tok Era for the Study of Long Noncoding RNAs in Pulmonary Hypertension. | Am J Respir Crit Care Med | 2020 |
| 32311291 | Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019. | Am J Respir Crit Care Med | 2020 |
| 32109446 | Outcomes of Pulmonary Arterial Hypertension Are Improved in a Specialty Care Center. | Chest | 2020 |
| 32493166 | Long Range Endocrine Delivery of Circulating miR-210 to Endothelium Promotes Pulmonary Hypertension. | Circ Res | 2020 |
| 32166015 | Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension. | Pulm Circ | 2020 |
| 32128158 | Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea. | Pulm Circ | 2020 |
| 31526282 | NFU1, Iron-Sulfur Biogenesis, and Pulmonary Arterial Hypertension: A (Metabolic) Shift in Our Thinking. | Am J Respir Cell Mol Biol | 2020 |
| 30280445 | The mir-200 family regulates key pathogenic events in ascending aortas of individuals with bicuspid aortic valves. | J Intern Med | 2019 |
| 31754458 | A network-based approach to uncover microRNA-mediated disease comorbidities and potential pathobiological implications. | NPJ Syst Biol Appl | 2019 |
| 30113078 | Evolving systems biology approaches to understanding non-coding RNAs in pulmonary hypertension. | J Physiol | 2019 |
| 31420607 | Rapamycin-upregulated miR-29b promotes mTORC1-hyperactive cell growth in TSC2-deficient cells by downregulating tumor suppressor retinoic acid receptor β (RARβ). | Oncogene | 2019 |
| 30773044 | The Search for Disease-Modifying Therapies in Pulmonary Hypertension. | J Cardiovasc Pharmacol Ther | 2019 |
| 31092016 | Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial Hypertension. | Arterioscler Thromb Vasc Biol | 2019 |